Blocking the activation of Sgk1 can ameliorate allodynia induced by spinal nerve ligation in rats, as well as the development of pathological pain responses and pain caused by inflammation, nerve injury, psychiatric disorders, and chronic opioid exposure (Liu et al., 2021; Peng et al., 2013). The gene discussed is SGK1; the disease is psychiatric disorder.